PortfoliosLab logoPortfoliosLab logo
ISIN
US30214U1025
CUSIP
30214U102
IPO Date
Aug 17, 1990

Highlights

Market Cap
$2.80B
Enterprise Value
$2.77B
EPS (TTM)
$2.14
PE Ratio
26.13
PEG Ratio
12.38
Total Revenue (TTM)
$436.51M
Gross Profit (TTM)
$95.87M
EBITDA (TTM)
$153.50M
Year Range
$51.91 - $81.95
Target Price
$85.00
ROA (TTM)
15.85%
ROE (TTM)
32.20%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

EXPO Performance Chart

Exponent, Inc. (EXPO) is down 18.8% since the beginning of the year. At $56 per share, EXPO is trading 31.8% below its 52-week high of $82. Investors who bought $1,000 worth of EXPO shares 5 years ago would now be looking at an investment worth $674.


Loading charts...

S&P 500 Index

Returns By Period

Exponent, Inc. (EXPO) has returned -18.81% so far this year and -21.98% over the past 12 months. Over the last ten years, EXPO has returned 8.47% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Exponent, Inc.

1D
-1.79%
1M
-2.78%
YTD
-18.81%
6M
-22.57%
1Y
-21.98%
3Y*
-14.75%
5Y*
-7.59%
10Y*
8.47%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EXPO Monthly Returns History

Based on dividend-adjusted daily data since Aug 17, 1990, EXPO's average daily return is +0.09%, while the average monthly return is +1.27%. At this rate, an investment would double in approximately 4.6 years.

Historically, 53% of months were positive and 47% were negative. The best month was Jul 1995 with a return of +39.4%, while the worst month was Mar 1992 at -30.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.

On a daily basis, EXPO closed higher 46% of trading days. The best single day was Oct 17, 1995 with a return of +27.8%, while the worst single day was Aug 13, 1991 at -25.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.47%1.27%-9.97%2.51%-12.81%-3.70%-18.81%
20252.88%-7.65%-3.90%-2.94%-2.97%-1.75%-7.70%3.51%-2.26%1.91%2.10%-3.54%-20.81%
20240.17%-8.28%2.58%11.15%3.49%0.30%11.52%2.06%6.76%-18.13%4.59%-9.47%2.42%
20233.48%0.35%-2.87%-7.66%-0.79%2.47%-4.01%0.31%-4.46%-14.38%5.01%14.76%-10.14%
2022-18.63%-0.23%14.31%-11.33%-5.66%1.47%9.86%-6.60%-6.36%8.66%8.56%-3.95%-14.25%
2021-8.28%16.82%1.22%-1.15%-5.29%-1.99%20.04%9.16%-3.04%1.46%1.48%0.37%30.67%

Benchmark Metrics

Exponent, Inc. has an annualized alpha of 15.91%, beta of 0.69, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 17, 1990.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (70.36%) than losses (56.42%) - typical of diversified or defensive assets.
  • Beta of 0.69 may look defensive, but with R2 of 0.07 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
15.91%
Beta
0.69
0.07
Upside Capture
70.36%
Downside Capture
56.42%

Return for Risk

Risk / Return Rank

EXPO ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


EXPO Risk / Return Rank: 1212
Overall Rank
EXPO Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
EXPO Sortino Ratio Rank: 1212
Sortino Ratio Rank
EXPO Omega Ratio Rank: 1414
Omega Ratio Rank
EXPO Calmar Ratio Rank: 1616
Calmar Ratio Rank
EXPO Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Exponent, Inc. (EXPO) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EXPOBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.74

Sortino ratioReturn per unit of downside risk

-3.71

Omega ratioGain probability vs. loss probability

0.89

1.37

-0.47

Calmar ratioReturn relative to maximum drawdown

-0.68

2.78

-3.46

Martin ratioReturn relative to average drawdown

-1.60

12.44

-14.04

Dividends

Dividend History

Exponent, Inc. provided a 2.18% dividend yield over the last twelve months, with an annual payout of $1.22 per share. The company has been increasing its dividends for 12 consecutive years.


0.60%0.80%1.00%1.20%1.40%1.60%1.80%$0.00$0.20$0.40$0.60$0.80$1.00$1.2020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.22$1.20$1.12$1.04$0.96$0.80$0.76$0.64$0.52$0.42$0.36$0.30

Dividend yield

2.18%1.73%1.26%1.18%0.97%0.69%0.84%0.93%1.03%1.18%1.19%1.20%

Monthly Dividends

The table displays the monthly dividend distributions for Exponent, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.31$0.00$0.00$0.31$0.62
2025$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$1.20
2024$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$1.12
2023$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$1.04
2022$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.96
2021$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.80

Dividend Yield & Payout


Dividend Yield

Exponent, Inc. has a dividend yield of 2.18%, which is quite average when compared to the overall market.

Payout Ratio

Exponent, Inc. has a payout ratio of 56.50%, which is quite average when compared to the overall market. This suggests that Exponent, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Exponent, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Exponent, Inc. was 86.44%, occurring on Apr 7, 1997. Recovery took 1954 trading sessions.

The current Exponent, Inc. drawdown is 52.69%.


Related event

Drawdown

Fall

Recovery

Underwater

1997 bear market1997
-86.44%Apr 1997
5y 12mo7y 9mo
13y 9moApr 1991 - Jan 2005
2026 bear market2026
-54.79%May 2026
4y 5mo
4y 6moDec 2021 - now
Financial crisis2007–2009
-46.19%Feb 2009
10mo 13d1y 9mo
2y 7moApr 2008 - Dec 2010
COVID crash2020
-27.75%Mar 2020
1mo 4d3mo 9d
4mo 13dFeb 2020 - Jul 2020
2005 bear market2005
-22.44%Feb 2005
27d5mo 14d
6mo 11dJan 2005 - Jul 2005

Drawdown Indicators


EXPOBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-86.44%

-56.78%

-29.66%

Max Drawdown (1Y)

Largest decline over 1 year

-32.45%

-9.10%

-23.35%

Max Drawdown (3Y)

Largest decline over 3 years

-52.37%

-18.90%

-33.47%

Max Drawdown (5Y)

Largest decline over 5 years

-54.79%

-25.43%

-29.36%

Max Drawdown (10Y)

Largest decline over 10 years

-54.79%

-33.92%

-20.87%

Current Drawdown

Current decline from peak

-52.69%

-1.80%

-50.89%

Average Drawdown

Average peak-to-trough decline

-32.74%

-10.71%

-22.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.73%

2.03%

+11.70%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Exponent, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Exponent, Inc. is priced in the market compared to other companies in the Consulting Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for EXPO, comparing it with other companies in the Consulting Services industry. Currently, EXPO has a P/E ratio of 26.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for EXPO compared to other companies in the Consulting Services industry. EXPO currently has a PEG ratio of 12.4. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for EXPO relative to other companies in the Consulting Services industry. Currently, EXPO has a P/S ratio of 6.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for EXPO in comparison with other companies in the Consulting Services industry. Currently, EXPO has a P/B value of 8.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with EXPO

Add Exponent, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with EXPO